Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
metoclopramide muscarinic acetylcholine receptor m1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Radiation[MeSHID:D011827]
Diagnosis[MeSHID:D003933]
Operative Surgical Procedures[MeSHID:D013514]
Gastroparesis[MeSHID:D018589]
Nose[MeSHID:D009666]
Pain[MeSHID:D010146]
Hiccup[MeSHID:D006606]
Recurrence (disease attribute)[MeSHID:D012008]
Disease[MeSHID:D004194]
Nausea[MeSHID:D009325]
Stomach[MeSHID:D013270]
Vomiting[MeSHID:D014839]
Gastroesophageal reflux disease[MeSHID:D005764]
Intestines
Small[MeSHID:D007421]
Gastric Emptying[MeSHID:D005746]
Bezoars[MeSHID:D001630]
Electromagnetic Radiation[MeSHID:D060733]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.29 approved,investigational agonist
metoclopramide dopamine d2 receptor small molecule Successful target TTD , drugbank , DGIDB Disease Management[MeSHID:D019468]
Radiation[MeSHID:D011827]
Diagnosis[MeSHID:D003933]
Operative Surgical Procedures[MeSHID:D013514]
Gastroparesis[MeSHID:D018589]
Nose[MeSHID:D009666]
Pain[MeSHID:D010146]
Hiccup[MeSHID:D006606]
Recurrence (disease attribute)[MeSHID:D012008]
Disease[MeSHID:D004194]
Nausea[MeSHID:D009325]
Stomach[MeSHID:D013270]
Vomiting[MeSHID:D014839]
Gastroesophageal reflux disease[MeSHID:D005764]
Intestines
Small[MeSHID:D007421]
Gastric Emptying[MeSHID:D005746]
Bezoars[MeSHID:D001630]
Electromagnetic Radiation[MeSHID:D060733]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.33 approved,investigational antagonist
metoclopramide 5-hydroxytryptamine receptor 3a small molecule NA drugbank Disease Management[MeSHID:D019468]
Radiation[MeSHID:D011827]
Diagnosis[MeSHID:D003933]
Operative Surgical Procedures[MeSHID:D013514]
Gastroparesis[MeSHID:D018589]
Nose[MeSHID:D009666]
Pain[MeSHID:D010146]
Hiccup[MeSHID:D006606]
Recurrence (disease attribute)[MeSHID:D012008]
Disease[MeSHID:D004194]
Nausea[MeSHID:D009325]
Stomach[MeSHID:D013270]
Vomiting[MeSHID:D014839]
Gastroesophageal reflux disease[MeSHID:D005764]
Intestines
Small[MeSHID:D007421]
Gastric Emptying[MeSHID:D005746]
Bezoars[MeSHID:D001630]
Electromagnetic Radiation[MeSHID:D060733]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational antagonist
metoclopramide 5-hydroxytryptamine receptor 4 small molecule NA drugbank Disease Management[MeSHID:D019468]
Radiation[MeSHID:D011827]
Diagnosis[MeSHID:D003933]
Operative Surgical Procedures[MeSHID:D013514]
Gastroparesis[MeSHID:D018589]
Nose[MeSHID:D009666]
Pain[MeSHID:D010146]
Hiccup[MeSHID:D006606]
Recurrence (disease attribute)[MeSHID:D012008]
Disease[MeSHID:D004194]
Nausea[MeSHID:D009325]
Stomach[MeSHID:D013270]
Vomiting[MeSHID:D014839]
Gastroesophageal reflux disease[MeSHID:D005764]
Intestines
Small[MeSHID:D007421]
Gastric Emptying[MeSHID:D005746]
Bezoars[MeSHID:D001630]
Electromagnetic Radiation[MeSHID:D060733]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational agonist
click here to return to the previous page